Whole exome or genome sequencing is becoming routine in clinical situations for identifying mutations underlying presumed genetic causes of disease, including infertility. While this is a powerful approach for implicating polymorphisms or de novo mutations in genes plausibly related to the phenotype, a greater challenge is to definitively prove causality. This is a crucial requisite for treatment, especially for infertility, in which validation options are limited. In this study, we created a mouse model of a putative infertility allele, DMC1 M200V . DMC1 encodes a RecA homolog essential for meiotic recombination and fertility in mice. This allele was originally implicated as being responsible for sterility of a homozygous African woman, a conclusion supported by subsequent biochemical analyses of the mutant protein and by studies of yeast with the orthologous amino acid change. Here, we found that Dmc1 M200V/M200V male and female mice are fully fertile and do not exhibit any gonadal abnormalities. Detailed immunocytological analysis of meiosis revealed no defects suggestive of compromised fertility. This study serves as a cautionary tale for making conclusions about consequences of genetic variants, especially with respect to infertility, and emphasizes the importance of conducting relevant biological assays for making accurate diagnoses in the era of genomic medicine.
INTRODUCTION
Surveys estimate that 10-15% of the United States population experiences some form of infertility (Chandra, 2013) , and it is believed that as many as half of infertility cases have an underlying genetic basis. Over the last decade, candidate gene sequencing and whole exome/genome re-sequencing have become increasingly used clinically for identifying potential causes of presumed genetic disorders, including infertility. Several studies have employed the general approach of identifying a candidate variant/mutation in a sterile patient(s), sequencing the suspect gene in a number of normal patients, and then suggesting causation of the candidate mutation if it is unique (or homozygous in) only the infertile people (Sato et al. 2006; Miyamoto et al. 2008; Miyamoto et al. 2009; França et al. 2017 ) However, such correlation is not proof, as illustrated in the case of a purported globozoospermia allele of Spata16 (Dam et al. 2007 ) that was shown by mouse modeling to not impact fertility (Fujihara et al. 2017) .
A major strategy for identifying and implicating putative disease-mutations is the use of algorithms designed to predict the impact of mutations on protein function. Popular algorithms such as Polyphen-2, SIFT, and FATHMM utilize direct or machine-learning strategies to assess protein sequence, structure, and amino acid properties to generate predictions (Kumar et al. 2009; Adzhubei et al. 2010; Shihab et al. 2013) . Nonetheless, recent work has found that the predictions of damaging alleles are frequently inaccurate, and many predicted null mutations cause subtle deficiencies at best (Wang et al. 2018; Miosge et al. 2015) . In addition, studies specifically aimed at fertility effects in vivo found that as low as 25% of predicted high-damaging variants cause any detectable phenotype (Singh and Schimenti 2015) . Although computational approaches can be useful, these studies emphasize that current algorithms may not be sufficiently reliable for high-confidence assessment of the physiological impact of variants, especially in a clinical context.
In this present study, we took a closer look at a variant of human DMC1, a methionine-to-valine change at amino acid position 200 (Dmc1 M200V ). Dmc1 is a meiosis-specific homolog of E. coli RecA and is essential for the repair of SPO11/TOP6BL-induced double strand breaks (DSBs) by homologous recombination (Yoshida et al. 1998; Bishop et al. 1992; Robert et al. 2016; Keeney et al. 1997 ), a process that is essential for pairing of chromosome homologs. Dmc1 knockout mice are sterile due to arrest of meiocytes stemming from failed homologous chromosome synapsis (Yoshida et al. 1998; D. Pittman et al. 1998 ) and activation of the meiotic DNA damage checkpoint (Bolcun-Filas et al. 2014) . DMC1 M200V was implicated as being responsible for premature ovarian failure in an African woman who was homozygous for this allele Hikiba et al. 2008) . Follow-up studies of this allele including crystallographic characterization, enzymatic assays, and phenotypic analysis of yeast bearing the orthologous amino acid change, demonstrated impaired function of the protein (Hikiba et al. 2008) . We sought to expand upon these findings by introducing the M200V allele in the mouse ortholog of Dmc1. Here, we report that Dmc1 M200V/M200V male and female mice are fertile, have normal fecundity and gamete numbers, and have no meiotic defects. Our findings underscore the potential difficulties in reliably assessing allele pathogenicity and argue for the use of relevant in vivo functional assays to guide therapeutic actions.
RESULTS

Dmc1 M200V/M200V mice are fertile and phenotypically similar to wild type
To generate mice modeling the human DMC1 M200V allele, CRISPR/Cas9-mediated genome editing in single-celled zygotes was performed. As diagrammed in Figure 1A and B, a single-stranded oligodeoxynucleotide (ssODN) was used as a template to introduce two nucleotide changes into codon 200 via homologous recombination, causing this codon to encode valine instead of methionine. Founder mice with the desired mutation were identified (Fig. 1C ), backcrossed into FVB/NJ for at least two generations, then intercrossed to generate heterozygous and homozygous mice for phenotypic analysis.
Male and female Dmc1 M200V/M200V mice did not show gross phenotypic abnormalities.
To assess the fertility status of these mice, eight-week old Dmc1 M200V/M200V male and female mice were housed with wild type mates over the course of four to eight months.
Litter sizes of these mutants vs controls were not significantly different ( Figure 2A ).
Thus, the Dmc1 M200V allele does not impair fertility or fecundity in mice.
To determine if the mutation caused subclinical gonadal defects, gross and histological analyses of testes and ovaries were performed. Eight-week old Dmc1 M200V/+ and Dmc1 M200V/M200V testis weights and sperm counts were indistinguishable from wild type ( Figure 2B , C). Similarly, mutant testis histology revealed no abnormalities in spermatogenesis ( Figure 2D ).
Although females had normal fecundity, it is possible that the mutation caused reduction in the ovarian reserve. Wild type and Dmc1 M200V/M200V ovaries were histologically indistinguishable ( Figure 2E ). We serially sectioned mutant and wild type ovaries and quantified the total number of primordial follicles in three-week old ovaries, revealing no significant difference ( Figure 2F ). These results are consistent with the breeding studies and provide no evidence of any compromise to gametogenesis in either sex.
DMC1 M200V does not disrupt meiotic chromosome behavior in mice
Despite having normal fertility, fecundity, and histology, it is possible that the M200V amino acid change has a mild effect only detectable at the cellular level. Dmc1 is a meiosis-specific recombinase that acts at sites of meiotically-programmed doublestrand breaks (DSBs) to catalyze D-loop formation and strand exchange between chromosomes, ultimately promoting chromosome pairing, synapsis, and recombination (Yoshida et al. 1998; Bishop et al. 1992; Schwacha and Kleckner 1997; D. L. Pittman et al. 1998) . As mentioned in the Introduction, in vitro assays showed that DMC1 M200V had altered biochemical activities under certain conditions, namely reduced ATPase activity at higher temperatures and reduced D-loop formation at low magnesium concentrations. Furthermore, the orthologous amino acid change in the fission yeast S. pombe caused a 50% reduction in recombination at two loci (Hikiba et al. 2008) . To detect any anomalies that may reflect defective function of DMC1 M200V during mouse meiosis, we conducted immunocytological analyses of surface-spread chromosomes from wild type and Dmc1 M200V/M200V spermatocytes, using markers diagnostic for certain key events of meiosis. First, we tested if DMC1 M200V localizes normally to meiotically-programmed DSBs. There was no significant difference in DMC1 focus numbers between wild type and Dmc1 M200V/M200V during the peak stages of DSB formation: leptonema and zygonema ( Figure 3A, B ). Normally, as meiotic prophase I progresses and DSBs are repaired by recombination, DSBs as marked by DMC1 foci along the lateral/axial elements of synaptonemal complexes (marked by SYCP3) decrease in zygonema and pachynema, ultimately disappearing in late pachynema. This was the case with Dmc1 M200V/M200V spermatocytes. These results indicate that DMC1 M200V is properly recruited to sites of meiotic DSBs, catalyzes homologous recombination repair of these DSBs which is essential for pairing of homologous chromosomes, and is properly released from processed DSBs following repair.
Next, we immunolabeled spreads with gH2AX, a histone variant phosphorylated at sites of DNA damage, which also serves as a marker of the transcriptionally silenced and heterochromatinized XY body that forms in pachynema (Burma et al. 2001 ). Similar to wild type, leptotene and zygotene Dmc1 M200V/M200V spermatocytes had high levels of gH2AX along chromosomes (data not shown) and by pachynema, gH2AX was exclusive to the X and Y chromosomes, indicative of complete DSB repair on autosomes and XY body formation ( Figure 3C ). We then immunolabeled chromosome spreads for synaptonemal complex (SC) transverse element protein SYCP1, which marks regions of complete synapsis between homologs. The former decorates the axial/lateral elements of the synaptonemal complex, while the latter is a component of the transverse element, and thus only stains synapsed regions of chromosomes. In the absence of DMC1, repair of meiotic DSBs does not occur, and homologous chromosomes do not synapse (D. Yoshida et al. 1998) . SC formation occurred normally in Dmc1 M200V/M200V spermatocytes as indicated by SYCP3/SYCP1 staining of pachytene chromosomes ( Figure 3D ). This suggests that DMC1 M200V does not affect homologous chromosome synapsis.
Meiotic DSBs are repaired by one of two mechanisms: the majority (~90%) as noncrossovers (NCOs) and the rest as crossovers (COs). While both types of events are important for driving homolog pairing and synapsis, chiasmata formed by CO events are essential for proper chromosome segregation at the first meiotic division. They ensure that homologs correctly align at the metaphase plate and segregate to opposite poles when the COs are resolved. To test whether crossover formation is affected in Dmc1 M200V/M200V mutants, we quantified MLH1 foci -a proxy for the predominant class of crossovers in mice -in pachytene spermatocyte nuclei ( Figure 3E ). Interestingly, whereas wild type spermatocytes had 23 ± 2.0 MLH1 foci/cell (mean±s.d., n=3, 96 cells), Dmc1 M200V/M200V had 22 ± 2.4 MLH1 foci/cell (mean±s.d., n=4, 120 cells), which is a small but statistically significant difference (p= 0.03; Figure 3F ).
One copy of Dmc1 M200V is sufficient for normal meiosis
Although fertility, fecundity, and meiotic prophase I chromosome behavior was normal in Dmc1 M200V/M200V mice, we considered the possibility that the mutant protein might be compromised in a subtle way that would only manifest under more challenging conditions. Accordingly, we bred mice hemizygous for Dmc1 M200V (Dmc1 M200V/-). The testis weights and sperm counts of eight-week old Dmc1 M200V/males were no different than wild type ( Figure 4A,B) , and testis histology was unremarkable ( Figure 4C ).
Likewise, females at three weeks of age had primordial follicle counts similar to wildtype ( Figure 4D ). Lastly, breeding Dmc1 M200V/animals to wildtype mates yielded normal sized litters; males sired an average of 8.8 pups/litter and females birthed 8.8 pups/litter (p= 0.55 and p= 0.90, respectively; Figure 2A ). These results provide further evidence that under in vivo conditions, DMC1 M200V has no substantial impact on fertility, fecundity, or gametogenesis.
DISCUSSION
Remarkable advances in genomics capabilities in the past few years are revolutionizing medicine. As DNA sequencing costs have dropped precipitously, it is becoming more routine to use whole-exome or -genome sequencing as clinical tests for certain common (namely, cancer) or rare diseases (such as undiagnosed developmental disorders). This will certainly become more commonplace for identifying The work presented here is part of an NIH-funded project (see acknowledgements)
we have undertaken to specifically address this issue (Singh and Schimenti 2015) , and our results serve to highlight the serious nature of the problem. The Dmc1 M200V allele was identified as a potentially causative infertility variant 10 years ago Hikiba et al. 2008 ) and associated work provided compelling evidence that the allele encoded a protein with altered biochemical activities that might be consistent with disrupted meiosis (Hikiba et al. 2008 ). However, our in vivo modeling of this allele showed that this allele, in mice, did not impact fertility or fecundity at all.
While we are of the opinion that in vivo modeling in mice is a more physiologicallyrelevant biological test than in vitro biochemical assays, there are still potential caveats.
One caveat is that although the mouse and human DMC1 proteins are 97% identical, it is possible that the M200V alteration is tolerated in mice but not humans. We consider this unlikely because there are no Dmc1 paralogs unique to mice, and the mouse gene is absolutely required for meiosis and fertility in mice. It is also conceivable that the gonadal environment in humans is such that the M200V change is catalytically more unstable in human meiocytes than in mouse meiocytes. For example, we found that in Dmc1 M200V/M200V spermatocytes, there was a slight decrease (<5%) in the number of MLH1 foci. However, the number of MLH1 foci varies amongst inbred strains (Anderson et al. 1999) , and since the founder mice were of mixed genetic background, it is possible that the variation is due to these differences, possibly linked to the Dmc1 locus. However, technology is dynamic, and with increasing numbers of in vivo studies and training data sets, these algorithms may become more accurate with time. Another indicator of whether an allele might cause infertility is allele frequency. As noted by He et al. (He et al. 2018) , the Dmc1 M200V has a high allelic frequency in African populations (12% according to the gnomAD database), which seems incompatible with it being an infertility allele.
In conclusion, this study highlights the importance of in vivo modeling to make accurate conclusions about putative infertility-associated polymorphisms or de novo mutations before taking clinical actions. While mice are currently the most accurate models for this (Singh and Schimenti 2015; Fujihara et al. 2017; Kherraf et al. 2018) , we anticipate that improvements to in vitro gametogenesis, especially with human cells, will be important for development of higher-throughput and lower-cost analysis for diagnostics of genetic causes of human infertility.
Materials and Methods
Generation of Dmc1 M200V Mice by CRISPR-Cas9 Genome Editing
An optimal guide sequence was selected using online software at mit.crispr.edu. The crRNA and CRISPR-Cas9 tracrRNA was synthesized by IDT (ALT-R service) and the ssODN was also synthesized by IDT's (Ultramer service). Prior to pronuclear injection, the crRNA (25 ng/µL) and tracrRNA (25 ng/µL) were co-incubated to form a ribonucleoprotein complex according to manufacturer's instructions. The ssODN (50 ng/µL) and additional CAS9 protein (1000 ng/µL; PNA Bio) were added, and all materials were co-injected into zygotes (F1 hybrids between strains FVB/NJ and B6(Cg)-Tyr c-2J /J), then transferred into the oviduct of pseudopregnant females.
Founders bearing at least one copy of the desired alteration were identified by PCR with primers flanking the SNP (Supp. Table I), then backcrossed into FVB/NJ. Initial phenotyping was performed after one backcross generation followed by intercrossing, then additional phenotyping was done with animals backcrossed an additional two or more generations. No phenotypic differences were found among different generations.
All animal use was conducted under a protocol (2004-0038) to J.C.S. and approved by Cornell University's Institutional Animal Use and Care Committee.
The Dmc1 tm1Jcs allele (referred to as Dmc1 +/in this manuscript) was previously described ).
All sequences used for CRISPR-Cas9 editing and mouse genotyping are in Supplementary Table I .
Genotyping of Dmc1 M200V and Dmc1 +/-Mice
Toe tissue was collected from pups at 8-14 days of age. A crude DNA lysate was made by disrupting tissue in Lysis Buffer (2.5 mM NaOH/0.2 mM EDTA, pH 12.2) at 95ºC for 60 minutes and neutralized by adding equal parts Neutralization Buffer (40 mM Tris-HCl, pH 4.6). PCR was done using Econotaq and associated reagents (Lucigen), following manufacturer's protocol with 3 µL of crude DNA lysate per reaction. Primers were ordered from IDT and sequences are listed in Supplementary Table I . The PCR cycle used for both Dmc1 M200V and Dmc1 +/mice PCR was: initial denature at 95ºC for 5 minutes, 30 cycles of 95ºC for 30 seconds -58ºC for 30 seconds -72ºC for 30 seconds, and final elongation at 72ºC for 5 minutes. For identification of Dmc1 +/mice, we used gel electrophoresis to analyze the presence of wildtype (167bp) and/or mutant PCR (250bp) products amplified by respective primers. For identification of Dmc1 M200V mice, PCR samples were digested with restriction enzyme TaqaI (NEB) at 65ºC for two hours then analyzed using gel electrophoresis. The wildtype allele is detected as two bands (444bp and 31bp) while the Dmc1 M200V allele is detected as three bands (244bp, 200bp, and 31bp).
Histology and Primordial Follicle Quantification
Testes were harvested from eight-week old males and fixed in Bouin's for 24 hours, washed in 70% ethanol for 24 hours, and embedded in paraffin. Sections of 6 µm were made and stained with hematoxylin and eosin. Ovaries were harvested from three week old females and prepared in the same way, then serial sectioned at 6 µm. Primordial follicles were counted in every fifth section and final follicle counts were calculated as previously described (Myers et al. 2004 ). Statistical analysis was done with a two-tailed student T-test on Prism 7 (GraphPad).
Sperm Counts
Epidydymides were isolated from eight-week old males. The tissue was minced in 5mL of MEM media and incubated at 37°C for 15 minutes, allowing spermatozoa to swim out. The spermatozoa were diluted 1:2 in MEM and counted using a hemacytometer.
Immunocytochemistry of Meiotic Chromosomes
We used a protocol that has been previously published (McNairn et al. 2017) . In brief, testes were isolated from eight-to twelve-week old males, detunicated, and minced in MEM media. Spermatocytes were hypotonically swollen in 4.5% sucrose solution, lysed in 0.1% Triton X-100, 0.02% SDS, and 2% formalin. Slides were washed and stained immediately or stored at -80°C. Blocking buffer used was 5% goat serum in PBS, 0.1% Tween20 and slides were blocked for 1 hour at room temperature. Primary antibodies and dilutions used were: anti-SYCP3 (1:600, Abcam, #ab15093), anti-SYCP3 (1:600, Abcam, #ab97672), anti-SYCP1 (1:400, Abcam, #ab15090), anti-DMC1
(1:100, Abcam, #ab11054), anti-MLH1 (1:100, BD Pharmingen, #554073), and antiphospho-H2A.X (1:1000, Millipore, #16-193) . Primary staining of chromosome surface spreads was done at 37°C and incubated overnight. Secondary antibodies used were: goat anti-mouse IgG AlexaFluor 488 (1:1000, ThermoFisher Scientific, #R37120) and goat anti-rabbit IgG AlexaFluor 594 (1:800, ThermoFisher Scientific, #R37117).
Secondary antibodies were incubated for 1 hour at room temperature. Images were acquired with an Olympus microscope with 40x lens using cellSens software (Olympus).
Foci were quantified using ImageJ with plugins Cell Counter (Kurt De Vos) and Nucleus Counter. All data was analyzed in Prism 7 (GraphPad). CCCCTCAGGTGAGCATCAGA Supplementary Table I 
